Asthmapolis, the creator of a platform that helps patients manage chronic respiratory diseases, has raised $5 million in Series A funding from The Social + Capital Partnership. In conjunction with the round, Ted Maidenberg, a general partner at Social + Capital, will join the Asthmapolis Board. Using sensors, mobile technology and personal support, Asthmapolis’ platform tracks when sufferers of asthma and COPD use their inhaled medications and offers personalized feedback to help them successfully manage their illnesses. The company has completed multiple financing rounds, including a seed round in 2012.
